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Abstract 
The “photoinitiated intramolecular ylide-alkene cycloaddition reaction” which was developed in 
our laboratory provides a method for construction of up to three rings and six chiral centers in a 
single experimental operation from relatively simple starting materials. This project has 
attempted to utilize this reaction to quickly synthesize novel materials which incorporate 
catechol bioisosteres into the organic scaffold in the hopes of imparting potentially useful bio-
activity to the new molecules. 
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Introduction 
Catechol 1 is a commonly seen motif in many active medicinal compounds such as Morphine 2, 
and Dopamine 3.  
 
 
 
 Bioisosteres of catechol, including benzoxazole 4 and benzothiazole 5 also commonly occur as 
motifs in a wide range of antibacterial, antifungal, non-narcotic analgesic, anti-inflammatory, 
anticancer, anti-HIV-1, and antimicrobial agents1, 2.  
 
 
 
 2 
 
A common method used for development of new drugs from known active compounds is via the 
introduction of bioisosteres. Bioisosteres are groups or molecules that have chemical and 
physical similarities producing broadly similar biological properties. Thus if one knows the 
pharmacophores, or groups in a molecule which are responsible for biological activity, one could 
systematically replace these with bioisosteric groups to generate new compounds with 
potentially improved therapeutic profiles. Thus novel compounds 6, 7, and 8 are logical targets 
for the development of new medicines.  
 
Our group has actively pursued development of procedures to build multicyclic scaffolds similar 
to those found in natural products3, 4. The method is based on a photoarylation procedure 
pioneered by A.G. Schultz and exemplified via the conversion 13→155.  
 
 
 
We sought to take advantage of the reactive ylide intermediate by appending a dipolarophile to 
the enone system as in 22. Synthesis of 22 is representative of the methods used in preparation of 
all photoprecursors used in this study. 
 
 3 
 
 
 
Upon photolysis it was observed that 22 underwent ring closure and subsequent intramolecular 
ylide alkene addition. At room temperature the predominant product 25 was consistent with ring 
closure to provide an ylide which underwent hydrogen shift as in Schultz's model 13→14→15. 
A second product 24 arising from ylide alkene addition was also observed. At higher temperature 
we observed exclusively ylide alkene addition products 26 and 24 in a 4:1 ratio3,4. 
 
 
 4 
 
 
Formation of the [3+2] products can be enhanced by addition of electron withdrawing groups on 
the side chain of 22. Therefore, photolysis of 22b in toluene (0.001 M) provides 28 as the only 
product, even at room temperature. Compound 22b was prepared from the acetal derivative of 22 
via (1) acetal hydrolysis followed by (2) Wittig addition to the resulting aldehyde3,4.  
 
 
 
With this established precedent, we predicted photolysis of 9 would provide carbonyl ylide 
intermediate 10 which would be expected to undergo a [3+2] intramolecular ylide-alkene 
cycloaddition to give 63, 4.  
 
 
 
Similarly, precursors 11 and 12 are expected to undergo the same transition to give products 7 
and 8 respectively.  
 
 5 
 
 
 
Former researchers in our lab have prepared substrates 29 and 32, which both contain 
heteroaromatic groups, in order to test the feasibility of performing a [3+2] ylide alkene 
cycloaddition on compounds similar to the target benzoxazole and benzothiazole derivatives. 
Photolysis of 29 in toluene at room temperature provided 30 in 60% yield and 31 in 30%. 
Similarly, photolysis of 32 in xylene at reflux gave 33 in 10% yield and 34 in 60%.  
 
 6 
 
 
 
The successful formation of 30 and 33 shows the feasibility of using heteroaromatic systems to 
promote the photoinitiated intramolecular [3+2] cycloaddition reaction. With this demonstrated 
precedent, it is likely that photoprecursors 9, 11, and 12 will undergo similar transformations to 
give the desired [3+2] cycloaddition products 6, 7 and 8 respectively. 
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Results and Discussion 
As noted in our introduction, this project addresses the synthesis and photochemical reactions of 
products 9, 11 and 12 as a means to prepare complex multi-cyclic scaffolds. 
 
 
 
In order to achieve maximum versatility in substrates for our studies, we selected the following 
general method of synthesis. 
 
 
 
Thus, synthesis of either epoxide 20 or 21 can give rise to a variety of substituted or non-
substituted alkene systems such as: 
 
        
 8 
 
 
Coupling of either epoxide with one of the three aromatic systems as shown gives rise to an array 
of aryl-vinyl ether photo precursors for use in our studies. 
 
 
 
Synthesis of epoxide 20 was achieved as follows. Reaction of 16 with p-toluene sulfonic acid (p-
TsOH) in ethanol-benzene provided 176. Grignard addition of (2-(1,3-dioxan-2-
yl)ethyl)magnesium bromide and subsequent acid workup yielded 18. Facile epoxidation of 18 
 9 
 
under basic conditions gave 20 in a 54% yield. Compound 20 shows peaks in the 1H NMR at δ 
1.17-1.39 (2 H), 1.72-2.41 (10 H), 3.68-3.80 (2 H), 4.02-4.15 (2 H), 4.45-4.53 (1 H), and 5.80-
5.88 (1 H). 
 
 
 
Similarly, epoxide 21 was prepared via Grignard addition of but-3-enylmagnesium bromide to 
17 followed by acid catalyzed hydrolysis to give 19 and subsequent treatment with basic 
hydrogen peroxide provided 21 in 74% yield. 21 showed peaks in the 1H NMR at δ 1.87-2.45 (10 
H), 4.87-5.10 (2 H), and 5.68-5.90 (2 H). 
 
 
 
 10 
 
Epoxide 21 incorporates a simple alkene side chain. Epoxide 20 incorporates a protected 
aldehyde which can subsequently be converted to a substituted alkene, where R can be electron 
withdrawing or electron donating (e.g. CO2Et or OMe respectively, illustrated below). 
 
      
 
 
Much of the prior successful work on building scaffolds similar to 6, 7 and 8 in our lab was 
conducted using the ethyl buteonate side chain. Accordingly, we selected the series of 
compounds 9, 11 and 12 as initial synthesis targets. 
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It was noted that benzoxazoles hydrolyzed under acidic conditions. Given the instability of 
benzoxazole toward acid and the need for an acid workup of 39 to form aldehyde 40, we turned 
our attention to an alternative approach to 40 via epoxide 21. This approach takes advantage of 
ozonolysis of the side chain olefin late in the synthesis to provide aldehyde 40 as shown7, 8. 
 
     
 
Synthesis of the bioisostere containing aryl groups 35, 36, and 37 was easily accomplished from 
commercially available materials. Compound 35 was synthesized via a two-step published 
procedure9, 10. Thus, addition of 42 to a mixture of hydroxylamine hydrochloride and sodium 
acetate in water provided 43. Treatment of 43 with phosphorous oxychloride (POCl3) in 
acetonitrile and dimethylformamide, followed by aqueous sodium acetate gave rise to 35 in 43% 
yield. Compound 35 displays 1H NMR peaks at δ 2.57 (3 H), 6.75 (1 H), 6.97 (1 H), 7.37 (1 H), 
and 9.67 (1 H). 
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Similarly, 36 was obtained in 85% yield via the same procedure starting with commercially 
available 44 and shows 1H NMR peaks at δ 2.53 (3 H), 6.65 – 6.75 (1 H), 6.82 – 6.84 (1 H), 7.43 
– 7.42 (1 H), and 9.48 (1 H). 
 
 
 
Benzothiazole 37 was obtained in a 70% yield from the commercially-available 46 upon 
treatment with 4 equivalents of BBr3 in methylene chloride, followed by slow addition of 
methanol and neutralization with sodium bicarbonate. Previous research in our laboratory found 
a temperature of -12oC was essential for the reaction to proceed in high yield11. Benzothiazole 37 
exhibits 1H NMR peaks at δ 2.42 – 2.48 (2 H), 6.64 – 6.66 (1 H), 7.02 – 7.22 (2 H), and 9.17 (1 
H). 
 
 
 
Once both the epoxide and the aryl-oxy systems were synthesized, we turned our attention to 
determine methods to couple the two systems together via an epoxide-opening reaction. 
Although procedures for preparing aryl-vinyl ether systems from epoxide 21 and various phenols 
had been developed in our laboratory, we chose to investigate some other attractive procedures 
 13 
 
in the hopes of attaining higher yields. In one published report, epoxides were successfully 
coupled with phenols to provide aryl-vinyl ether systems as shown below12, 13. 
  
 
 
In our trials however, this approach failed to provide product under a variety of concentrations 
and conditions. 
 
 
 
In another approach, we attempted to affect the coupling between 47 and 48 with potassium 
hydride (30% by weight in mineral oil) and dimethylformamide. 
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When this attempt failed, we turned our attention to the method previously developed in our 
laboratory and typified by the scheme below5. 
 
 
 
In order to evaluate this method for use with heterocyclic aromatic systems, we tested the 
conditions for synthesis of 51 from the readily available 47 and 50. 
  
 
 
After heating at reflux temperature for one day, followed by standard workup, aryl-vinyl ether 51 
was collected in 47% yield. Following this success, coupling was done using epoxide 21 with the 
two benzoxazoles and one benzothiazole under the same conditions. 
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Epoxide 21 and benzoxazole 35 were allowed to heat at reflux temperature for two days, after 
which, a standard workup and a wash with 1 N sodium hydroxide were performed to afford aryl-
vinyl ether 38 in a 35% yield. Compound 38 shows 1H NMR peaks at δ 2.05 – 2.14 (10 H), 2.57 
(3 H), 4.99 – 5.04 (2 H), 5.75 – 5.80 (1 H), 6.87 – 6.89 (1 H), 6.93 – 6.95 (1 H), and 7.65 – 7.69 
(1 H). This same procedure was used to couple epoxide 21 and benzoxazole 36 to afford aryl-
vinyl ether 52 in 40% yield. Compound 52 displays 1H NMR peaks at δ 1.54-2.17 (10 H), 2.53 
(3 H), 4.88-5.01 (2 H), 5.65-5.78 (1 H), 6.74-6.79 (1 H), 7.04-7.07 (1 H), and 7.18-7.25 (1 H). 
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Epoxide 21and benzothiazole 37 were heated at reflux temperature for two days using the 
standardized procedure of KH and DMPU in THF. A standard workup and purification by 
column chromatography on silica gel (methylene chloride : methanol (98:2)) afforded pure aryl-
vinyl ether 53 in 45% yield. Aryl-vinyl ether 53 showed peaks in the 1H NMR at δ 2.06-2.12 (2 
H), 2.22-2.28 (2 H), 2.42 (2 H), 2.54-2.58 (4 H), 4.98 (1 H), 5.03 (1 H), 5.09 (2 H), 5.70-5.79 (1 
H), 6.86 (1 H), 7.07 (1 H), and 7.42 (1 H). 
 
The next step in the synthesis is to oxidize the simple alkene side-chain to an aldehyde via 
ozonolysis followed by a reductive workup using dimethylsulfide7. Compounds 38 and 52 may 
be converted to compounds 54 and 55 through simple ozonolysis at -78 °C. 
 
 
 
Compound 53 may be converted to compound 56 through ozonolysis; however, the primary 
amine group on 53 must first be protected as the amine salt using perchloric acid8. 
 
 17 
 
 
 
Following the formation of aldehydes 54, 55, and 56, Wittig addition may provide a convenient 
path to photolysis precursors, 9, 11, and 12 respectively. 
 
 
 
 
 18 
 
Before attempting photocyclization of our precursors, and in order to gain experience, aryl-vinyl 
ether 57 was dissolved in toluene and irradiated for thirty minutes. 1H-NMR shows that the 
compound formed from the photoreaction was the trans-product, 58. 
 
 
 
The photo precursors synthesized in our lab will be irradiated in toluene according to conditions 
used previously and are expected to undergo photocyclization followed by an intramolecular 
[3+2] cycloaddition to form products 6, 7 and 8. 
 
 
 
 19 
 
 
 
In conclusion, aryl-vinyl ether systems 38, 52, and 53 were successfully synthesized. Future 
work will entail conversion of these substrates to photoprecursors 9, 11, and 12, which will be 
employed to construct multi-cyclic scaffolds via photochemical methods developed in our 
laboratory to provide 6, 7, and 8. 
 
 20 
 
 
Experimental 
General Methods 
 
1H NMR spectra were recorded on a Bruker 400 (400 MHz) NMR Spectrometer or a Bruker 500 
(500 MHz) NMR Spectrometer. Chemical shifts (δ) are reported in ppm relative to 
tetramethylsilane (TMS) at 0.00. 13C NMR spectra were recorded at 100.61 MHz. 
 
Infrared spectra (IR) were recorded on a Bruker Vertex 70 Infrared Spectrometer with a 4 cm-1 
resolution, scanning from 4000 to 650 cm-1 over 4 scans. 
 
Analytical thin-layer chromatography were done on precoated silica gel plates (0.25 mm 
thickness) with a 254 nm fluorescent indicator and were visualized under a UV lamp and/or by 
staining with either iodine or a p-anisaldehyde stain. 
 21 
 
3-ethoxy-2-cyclohexenone (17) 
 
 
 
To a 500-mL two-neck flask equipped with a reflux condenser and Dean Stark trap was added 3-
hydroxycyclohex-2-enone 16 (10.3 g, 91.6 mmol), ethanol (50 mL), benzene (175 mL) and p-
toluene sulfonic acid monohydrate (441 mg, 2.3 mmol). The resulting solution was stirred at 
room temperature for 4 h. The resulting clear, amber solution was heated at reflux temperature 
for 2 h after which it was allowed to cool to room temperature. Solvent was removed under 
reduced pressure and the resulting oil was dissolved in ethyl acetate, washed with a sodium 
hydroxide solution (10% aqueous saturated with sodium chloride), followed by water until 
neutral and then washed with brine. The organic layer was collected, dried (Na2SO4) and the 
solvent was removed under reduced pressure to yield 17 as an amber colored oil (8.66 g, 67.5%): 
1H NMR (CDCl3, 400 MHz) δ 1.40 (t, 3 H), 1.89-2.42 (m, 6 H), 3.91 (q, 2 H), 5.37 (s, 1 H); 13C 
NMR (CDCl3, 100.6 MHz) δ14.5, 21.6, 29.5, 37.1, 64.6, 103.1, 178.4, 200.4. 
 22 
 
3-(2-(1,3-dioxan-2-yl)ethyl)cyclohex-2-enone (18) 
 
 
 
Magnesium turnings (2.31 g, 95.2 mmol) were added to a dry 250-mL three-neck flask under 
nitrogen. Anhydrous tetrahydrofuran (THF, 10 mL) followed by 2-(2-bromoethyl)-1,3-dioxane 
(9.26 mL, 13.3 g, 68.3 mmol) was added along with additional THF (40 mL). The reaction 
mixture was allowed to reflux under exothermic heat for 10 min and the resulting mixture was 
refluxed with heating for an additional 30 min. The reaction mixture was cooled to 0 oC and a 
solution of 17 (8.25 g, 58.8 mmol) in THF (40ml) was added dropwise over 30 min. The 
resulting solution was allowed to stir at room temperature over the weekend and was neutralized 
with saturated aqueous ammonium chloride, and the solvent removed under reduced pressure. 
The resulting oil was dissolved in ethyl acetate, washed with water and brine and dried 
(Na2SO4). The solvent was removed under reduced pressure to yield an amber oil, which was 
diluted in ethanol, cooled to 0 °C, and slowly treated with aqueous hydrochloric acid (3.7%, 13.3 
mL). The resulting solution was allowed to warm to room temperature and stirred for 4 h. The 
resulting solution was neutralized with saturated aqueous sodium bicarbonate and concentrated 
under reduced pressure. The resulting oil was diluted with ethyl acetate and washed with water, 
brine, and dried (Na2SO4). Removal of solvent under reduced pressure yielded 18 as an amber oil 
 23 
 
(9.31 g, 75.3%): 1H NMR (CDCl3, 400 MHz) δ 1.17-1.39 (m, 2 H), 1.72-2.41 (m, 10 H), 3.68-
3.80 (m, 2 H), 4.02-4.15 (m, 2 H), 4.45-4.53 (m, 1 H), 5.80-5.88 (m, 1 H). 
 24 
 
3-(but-3-enyl)cyclohex-2-enone (19) 
 
 
 
To a mixture of magnesium turnings (0.28 g, 12 mmol) in dry THF (2 mL) under nitrogen was 
added 4-bromo-1-butene (0.85 mL, 8.3 mmol) in THF (4 mL). The mixture was maintained at 
reflux temperature for 45 min, after which it was cooled to 0 °C and compound 17 (0.96 mL, 
7.12 mmol) in THF (5 mL) was added. The solution was stirred at room temperature for 22 h and 
then was filtered. To the filtrate was added saturated aqueous ammonium chloride (5 mL) and 
the solvent was removed under reduced pressure. The crude product was taken up in ethyl 
acetate, washed with water, brine, and dried (Na2SO4) and the solvent was removed under 
reduced pressure. The resulting oil was taken up in ethanol and cooled to 0 °C. Aqueous 
hydrochloric acid (3.7%, 1.7 mL) was added dropwise and the mixture was stirred at 0 °C for 3 
h, allowed to warm to room temperature, neutralized with saturated aqueous sodium bicarbonate 
and concentrated under reduced pressure. Product was extracted from the resulting liquid with 
ethyl acetate and the organic layer was washed with water, brine and dried (Na2SO4). Solvent 
was removed under reduced pressure to yield 19 as a yellow oil (638 mg, 62 %): 1H NMR 
(CDCl3, 400 MHz) δ 1.87-2.45 (m, 10 H), 4.87-5.10 (m, 2 H), 5.68-5.90 (m, 2 H). 
 25 
 
6-(2-(1,3-dioxan-2-yl)ethyl)-7-oxabicyclo[4.1.0]heptan-2-one (20) 
 
 
 
To a 500-mL flask containing methanol (147 mL) at 10 oC was added 18 (9.28 g, 44.1 mmol) 
and hydrogen peroxide (35%, 9.9 mL, 115 mmol). Aqueous sodium hydroxide (0.5 M, 98 mL) 
was added over 75 min and the temperature was maintained at 10-12 oC. The resulting solution 
was allowed to stir an additional 50 min at 10-12 oC, after which it was extracted with 
dichloromethane. The combined organic layers were washed with brine and dried (Na2SO4). 
Solvent was removed under reduced pressure to yield 20 as a yellow colored oil (5.38 g, 53.9%): 
1H-NMR (CDCl3, 400 MHz) δ 1.18-1.38 (m, 2 H), 1.75-2.38 (m, 10 H), 3.12 (s, 1 H), 3.68-3.80 
(m, 2 H), 4.03-4.16 (m, 2 H), 4.45-4.52 (m, 1 H). 
 26 
 
6-(but-3-enyl)-7-oxabicyclo[4.1.0]heptan-2-one (21) 
 
 
 
A solution of 19 (638 mg, 4.3 mmol) in methanol was cooled to 10 °C and hydrogen peroxide 
(35%, 0.98 mL, 11 mmol) was added dropwise. Aqueous sodium hydroxide (0.5 M, 10 mL) was 
added over 16 min via addition funnel and stirring was continued for 1 h at 10-12 °C. The 
reaction mixture was extracted with dichloromethane and the combined organic layers were 
washed with brine and dried (Na2SO4). Solvent was removed under reduced pressure to yield 21 
as an oil (540 mg, 74 %): 1H NMR (CDCl3, 400 MHz) δ 1.45-2.57 (m, 10 H), 3.11 (s, 1 H), 4.89-
5.10 (m, 2 H), 5.69-5.92 (m, 1 H). 
 27 
 
3,5,5-trimethyl-2-(6-methylpyridin-3-yloxy)cyclohex-2-enone (51) 
 
 
 
To a solution of 3-hydroxy-6-methylpyridine 50 (600 mg, 5.5 mmol) in anhydrous THF (10 mL) 
was added potassium hydride (30% by weight in mineral oil, 6 drops). The resulting mixture was 
stirred for 10 min after which isophorone oxide 47 (0.78 mL, 5.0 mmol) was added followed by 
1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU, 0.66 mL, 5.5 mmol). The resulting 
solution was stirred at reflux temperature for 25 h. The resulting mixture was cooled to room 
temperature and partitioned between ethyl acetate and water. The organic phase was washed with 
water, brine, dried (Na2SO4), and the solvent was removed under reduced pressure. The resulting 
oil was dissolved in hexane, filtered, and washed with sodium hydroxide (1 N), water, and brine. 
The organic layer was collected, dried (Na2SO4). The solvent was removed under reduced 
pressure to yield 51 as an amber colored oil (0.58 g, 47.4%): 1H NMR (CDCl3, 400 MHz) δ 0.91 
(s, 6 H), 1.63 (s, 3 H), 2.14 (s, 2 H), 2.18 (s, 2 H), 2.25 (s, 3 H), 6.86 (m, 2 H), 7.88 (m, 1 H). 
 28 
 
2-aminobenzo[d]thiazol-6-ol (37) 
 
 
 
To a 100-mL round-bottom flask was added compound 46 (1.002 g, 5.56 mmol) in anhydrous 
dichloromethane (5.6 mL). The resulting solution was stirred at -12 oC. boron tribromide (1.0 M 
in methylene chloride, ~28 mL, 28 mmol) was added dropwise under nitrogen and the resulting 
reaction mixture was stirred at -9 to -12 oC for 3 h, at which point, starting material was no 
longer visible by thin layer chromatography (TLC) analysis (Hexanes : Ethyl Acetate (50:50)). 
Methanol (2.8 mL, 69.1 mmol) was slowly added, resulting in formation of a white gas. A light 
colored solid slowly formed and the flask was allowed to warm to room temperature with 
stirring. After 2.5 h, the solid was collected, dissolved in water and washed with ethyl acetate. 
The aqueous layer was collected and neutralized with saturated aqueous sodium bicarbonate. 
Evolution of gas was observed with concomitant formation of light grey solid. The mixture was 
filtered to yield 37 as a light grey solid (0.6454 g, 69.8%): 1H NMR (DMSO-d6, 400 MHz) δ 
2.42 – 2.48 (m, 2 H), 6.64 – 6.66 (m, 1 H), 7.02 – 7.22 (m, 2 H), 9.17 (s, 1 H). 
 29 
 
(E)-1-(2,5-dihydroxyphenyl)ethanone oxime (45) 
 
 
 
To a mixture of hydroxylamine hydrochloride (5.14 g, 73.9 mmol) and sodium acetate (10.2 g, 
125 mmol) in water (15 mL) was added a solution of 2’,5’-dihydroxyacetophenone 44 (3.00 g, 
19.7 mmol) in water (15 mL). The mixture was heated at reflux temperature for 2 h, and the 
crude mixture was extracted with ethyl acetate. The combined organic layers were washed with 
water, brine, dried (Na2SO4). The solvent was removed under reduced pressure to yield 45 as a 
brown solid (3.20 g, 97%): 1H NMR (CDCl3, 400 MHz) δ 2.19 (s, 3 H), 6.68 (d, 2 H), 6.83 (s, 1 
H), 8.96 (s, 1 H), 10.86 (dd, 1 H), 11.53 (d, 1 H). 
 30 
 
(E)-1-(2,4-dihydroxyphenyl)ethanone oxime (43) 
 
 
 
To a solution of hydroxylamine hydrochloride (4.61 g, 66 mmol) and sodium acetate (9.18 g, 
112 mmol) in water (15 mL) was added 2’,4’-dihydroxyacetophenone 42 (3.00 g, 20 mmol) and 
water (20 mL). The solution was heated at reflux temperature for 75 min after which product was 
extracted with ethyl acetate. The combined organic phases were washed with water, brine and 
dried (Na2SO4). Removal of solvent provided 43 as a light orange solid (3.10 g, 94%): 1H NMR 
(DMSO-d6, 400 MHz) δ 2.19 (s, 3 H), 6.24 (t, J=2.78 Hz, 1 H), 6.31 (m, 1 H), 7.28 (m, 1 H), 
9.82 (broad s, 1 H), 11.26 (broad s, 1 H), 11.78 (s, 1 H). 
 31 
 
2-methylbenzo[d]oxazol-5-ol (36) 
 
 
 
A solution of oxime 45 (1.50 g, 9 mmol) in dry acetonitrile (1.8 mL) and dry dimethylformide 
(5.4 mL) was treated with phosphorous oxychloride (0.85 mL, 9.1 mmol) over a period of 3 min. 
During the addition, the temperature was maintained below 30 °C. The resulting mixture was 
stirred at room temperature for 60 min. Aqueous sodium acetate (1.75 M, 15 mL) was added and 
stirring was continued for 5 min. The crude product was extracted with ethyl acetate. The 
combined organic phases were washed with water, brine and dried (Na2SO4). Removal of solvent 
provided 36 as a tan solid (1.14 g, 85 %): 1H NMR (DMSO-d6, 400 MHz) δ 2.53 (s, 3 H), 6.65 – 
6.75 (m, 1 H), 6.82 – 6.84 (m, 1 H), 7.43 – 7.42 (m, 1 H), 9.48 (s, 1 H). 
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2-methylbenzo[d]oxazol-6-ol (35) 
 
 
 
A solution of oxime 43 (1.50 g, 9 mmol) in dry acetonitrile (1.8 mL) and dry dimethylformide 
(5.4 mL) was treated with phosphorous oxychloride (0.84 mL, 9 mmol) over a period of 2 min. 
During the addition, the temperature was maintained below 30 °C. The resulting mixture was 
stirred at room temperature for 75 min. Aqueous sodium acetate (1.32 M, 20 mL) was added and 
stirring was continued for 5 min. The crude product was extracted with ethyl acetate. The 
combined organic phases were washed with water, brine and dried (Na2SO4). Removal of solvent 
provided a brown solid (2.07 g) and recrystallization from acetonitrile yielded 35 as a light 
brown solid (.582 g, 43%): 1H NMR (DMSO-d6, 400 MHz) δ 2.57 (s, 3 H), 6.75 (m, 1 H), 6.97 
(m, 1 H), 7.37 (m, 1 H), 9.67 (s, 1 H). 
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2-(2-aminobenzo[d]thiazol-6-yloxy)-3-(but-3-enyl)cyclohex-2-enone (53) 
 
 
 
To a solution of phenol 37 (0.2205 g, 1.33 mmol) in dry THF (2.4 mL) at 0 oC was added 
potassium hydride (30% by weight in mineral oil, 2 drops), resulting in a green cloudy reaction 
mixture. Compound 21 (0.20 mL, 1.20 mmol) and DMPU (0.16 mL, 1.32 mmol) were added and 
the mixture was stirred for 10 min at 0 oC. The reaction mixture was heated at reflux temperature 
for 63 h. The resulting dark brown reaction mixture was cooled to room temperature, after which 
the solvent was removed under reduced pressure. The resulting dark oil was dissolved in ethyl 
acetate, washed with water, brine, and dried (Na2SO4). Solvent was removed under reduced 
pressure to yield a viscous brown oil (0.5709 g), which was dissolved in chloroform and filtered 
(solid 0.0590 g). The brown filtrate was concentrated under reduced pressure to yield a brown-
orange residue (0.4259 g). Purification by column chromatography over silica gel (methylene 
chloride : methanol (98:2)) provided 53 as a brown solid (0.161 g, 44.7%): IR (film) 3382, 3107, 
2954, 1676, 1633 cm-1; 1H NMR (CDCl3, 500 MHz) δ 2.06-2.12 (m, 2 H), 2.22-2.28 (m, 2 H), 
2.42 (t, 2 H), 2.54-2.58 (m, 4 H), 4.98 (dq, 1 H), 5.03 (dq, 1 H), 5.09 (broad s, 2 H), 5.70-5.79 
(m, 1 H), 6.86 (dd, 1 H), 7.07 (d, 1 H), 7.42 (d, 1 H). 
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3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone (52) 
 
 
 
A solution of alcohol 36 (155.6 mg, 1.05 mmol), dry tetrahydrofuran (1.5 mL) and potassium 
hydride (35% in mineral oil, 222 mg, 0.14 mmol) was stirred at ice-bath temperature under a 
nitrogen environment while a solution of epoxide 21 (156.0 mg, 0.95 mmol) in dry THF (0.4 
mL) was added over 2 min. The mixture was heated at reflux temperature for 24 h after which 
product was extracted with ethyl acetate. The organic phase was washed with water, brine and 
dried (Na2SO4). Removal of solvent yielded 52 as an impure dark brown solid (263.5 mg, 85%): 
IR (film) 3076, 2927, 1680, 1618 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.54-2.17 (m, 10 H), 2.53 
(s, 3 H), 4.88-5.01 (m, 2 H), 5.65-5.78 (m, 1 H), 6.74-6.79 (m, 1 H), 7.04-7.07 (m, 1 H), 7.18-
7.25 (m, 1 H). 
 35 
 
3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-6-yloxy)cyclohex-2-enone (38) 
 
 
 
A solution of alcohol 35 (302.8 mg, 1.82 mmol), dry tetrahydrofuran (THF, 3 mL) and potassium 
hydride (35% in mineral oil, 11.07 mg, 0.28 mmol) was stirred at ice-bath temperature under a 
nitrogen environment while a solution of epoxide 21 (304.7 mg, 0.95 mmol) in dry THF (0.6 
mL) was added over 2 min. The mixture was heated at reflux temperature for 48 h after which 
product was extracted with ethyl acetate. The organic phase was washed with water, sodium 
hydroxide (1 N), brine and dried (Na2SO4). Removal of solvent followed by purification by 
column chromatography over silica gel (methylene chloride : methanol (99:1)) yielded 38 as a 
viscous yellow liquid (188 mg, 35%): IR (film) 3078, 2945, 2859, 1711, 1613 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 2.05 – 2.14 (m, 10 H), 2.57 (s, 3 H), 4.99 – 5.04 (m, 2 H), 5.75 – 5.80 (m, 1 
H), 6.87 – 6.89 (m, 1 H), 6.93 – 6.95 (m, 1 H), 7.65 – 7.69 (m, 1 H). 
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Spectra 
 
Figure 1 1H NMR Spectra of 3-ethoxy-2-cyclohexenone (17) 
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Figure 2 1H NMR Spectra of 3-(2-(1,3-dioxan-2-yl)ethyl)cyclohex-2-enone (18) 
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Figure 3 1H NMR Spectra of 3-(but-3-enyl)cyclohex-2-enone (19) 
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Figure 4 1H NMR Spectra of 6-(2-(1,3-dioxan-2-yl)ethyl-7-oxabicyclo[4.1.0]heptan-2-one (20) 
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Figure 5 1H NMR Spectra of 6-(but-3-enyl)-7-oxabicyclo[4.1.0]heptan-2-one (21) 
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Figure 6 1H NMR Spectra of 3,5,5-trimethyl-2-(6-methylpyridin-3-yloxy)cyclohex-2-enone (51) 
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Figure 7 1H NMR Spectra of 2-aminobenzo[d]thiazol-6-ol (37) 
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Figure 8 1H NMR Spectra of (E)-1-(2,5-dihydroxyphenyl)ethanone oxime (45) (-1 to 11 ppm) 
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Figure 9 1H NMR Spectra of (E)-1-(2,5-dihydroxyphenyl)ethanone oxime (45) (0 to 12 ppm) 
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Figure 10 1H NMR Spectra of (E)-1-(2,4-dihydroxyphenyl)ethanone oxime (43) (-1 to 11 ppm) 
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Figure 11 1H NMR Spectra of (E)-1-(2,4-dihydroxyphenyl)ethanone oxime (43) (0 to 12 ppm) 
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Figure 12 1H NMR Spectra of 2-methylbenzo[d]oxazol-5-ol (36) 
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Figure 13 1H NMR Spectra of 2-methylbenzo[d]oxazol-6-ol (35) 
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Figure 14 1H NMR Spectra of 2-(2-aminobenzo[d]thiazol-6-yloxy)-3-(but-3-enyl)cyclohex-2-enone (53) 
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Figure 15 IR Spectra of 2-(2-aminobenzo[d]thiazol-6-yloxy)-3-(but-3-enyl)cyclohex-2-enone (53) 
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Figure 16 1H NMR Spectra of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone (52) 
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Figure 17 IR Spectra of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone (52) 
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Figure 18 1H NMR Spectra of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-6-yloxy)cyclohex-2-enone (38) 
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Figure 19 IR Spectra of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-6-yloxy)cyclohex-2-enone (38) 
